Clay Siegall gives hope for new and better cancer treatment.

Clay Siegall gives hope for new and better cancer treatment.

Dr. Clay Siegall is a renowned professional and entrepreneur in the field of medicine. He is the founder of a drug development company for cancer patients known as Seattle Genetics. The company was launched in 1998. Clay Siegall received his Bachelors in Zoology from the University of Maryland and also holds a Ph.D. from the George Washington University. Clay Siegall has been the driving force behind the success of Seattle Genetics in developing antibody-drug conjugates-ADC which was first approved by the FDA in 2011. Seattle Genetics products such as ADCetrics are now accepted globally, and the organization is now raising the bar for proprietary ADCs used to treat cancer. Having had a firsthand experience of a close family member who was using cancer treatment that did more harm than good he wanted to find a better way for treatment. Clay Siegall desired to restore health to those afflicted by chronic diseases such as cancer. Since their first breakthrough for Seattle Genetics’ FDA approved drug ADC, the company has earned a substantial amount of revenue. This has been achieved through partnerships for production and licensing of the technologies that Seattle Genetics has developed. Despite the fact that the company might have encountered few stumbling blocks, Clay Siegall forged ahead. Since their first IPO, the company has grown exponentially over a period of 10 years. The products of Seattle Genetics have a viable market and have been recognized and recommended globally. Clay Siegall also has a team of salespeople that work tirelessly to market the products for the company further contributing to the success. Clay Siegall is a firm believer that with hard work and focus success could indeed be achieved. He is also a student of life and learns as much as he can the reason he recommends surrounding oneself with people who have expertise in many areas. Teamwork has been Clay Siegall’s strategy to grow the business. Through collaborations and partnerships, the company has been able to extend its reach in terms of technology. Seattle Genetics will indeed take the drug development industry by storm under the able leadership of Clay Siegall.